Imatinib Mesylate, Increased Bone Formation, and Secondary Hyperparathyroidism.
Login
University Home
→
Library
JavaScript is disabled for your browser. Some features of this site may not work without it.
Imatinib Mesylate, Increased Bone Formation, and Secondary Hyperparathyroidism.
Grey, Andrew
;
O'Sullivan, Susannah
;
Reid, Ian
;
Browett, Peter
Identifier:
http://hdl.handle.net/2292/13793
Issue Date:
2006
Reference:
NEW ENGLAND JOURNAL OF MEDICINE 355(23):2494-2495 07 Dec 2006
Rights:
Copyright: Massachusetts Medical Society
Rights (URI):
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
Abstract:
To the Editor: In a recent cross-sectional study, Berman et al. found that some patients who were treated with imatinib mesylate had hypophos
Show full item record
Files in this item
There are no files associated with this item.
DOI:
10.1056/NEJMc062388z
This item appears in the following Collection(s)
Journal Articles
[23194]
Share
Search ResearchSpace
Search ResearchSpace
This Collection
Browse
All of ResearchSpace
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Statistics
View Usage Statistics